Вакцины против гриппа лошадей

Автор: Костина Л.В., Гребенникова Т.В., Забережный А.Д., Алипер Т.И.

Журнал: Сельскохозяйственная биология @agrobiology

Рубрика: Обзоры

Статья в выпуске: 2 т.54, 2019 года.

Бесплатный доступ

Грипп лошадей - высокоинфекционное заболевание, характеризующееся тенденцией к быстрому распространению и высокой заболеваемостью среди чувствительного поголовья (К.П. Юров, 2009; S.P. Waghmare с соавт., 2010). Возбудитель гриппа лошадей - РНК-содержащий вирус, относящийся к семейству Orthomyxoviridaе , роду Influеnzavirus (Забережный А.Д. с соавт., 2017). На основании антигенных различий двух поверхностных гликопротеинов (HA и NA) выделяют два подтипа вируса гриппа лошадей (ВГЛ). Первый подтип (H7N7, equi-1), представленный прототипным штаммом A/equine/1/Prague/56, который впервые выделен в Чехословакии в 1956 году, менее вирулентный. Вспышки заболевания, вызванные им, не регистрируются с 1979 года. Второй подтип ВГЛ (H3N8, equi-2) циркулирует в большинстве стран мира, кроме Австралии, Новой Зеландии и Исландии, вызывая энзоотии в Америке и Европе (R. Paillot, 2014; B. Cowled с соавт., 2009; C.O. Perglione с соавт, 2016; A.I. Kydyrmanov с соавт., 2009). Вакцинация против гриппа лошадей, наряду с карантинными и ограничительными мерами, служит одним из основных инструментов по контролю заболевания (S.S...

Еще

Вирус гриппа лошадей, вакцинация, цельновирионные вакцины, субъединичные вакцины, аттенуированные вакцины, вакцины на основе векторов, рекомбинантные вакцины, методы обратной генетики

Короткий адрес: https://sciup.org/142220098

IDR: 142220098   |   DOI: 10.15389/agrobiology.2019.2.216rus

Список литературы Вакцины против гриппа лошадей

  • Юров К.П. Грипп лошадей. Ветеринария, 2009, 6: 3-7.
  • Waghmare S.P., Mode S.G., Kolte A.Y., Babhulkar N., Vyavahare S.H., Patel A. Equine influenza: an overview. Veterinary World, 2010, 3(4): 194-197.
  • Paillot R. A systematic review of recent advances in equine influenza vaccination. Vaccines, 2014, 2(4): 797-831 ( ) DOI: 10.3390/vaccines2040797
  • Забережный А.Д., Костина Л.В., Южаков А.Г., Гулюкина И.А., Степанова Т.В., Стаффорд В.В., Полякова И.В., Дроздова Е.И. Современная таксономия вирусов. Ветеринария и кормление, 2017, 1: 4.
  • Singh G. Characterization of A/eq-1 virus isolated during the equine influenza epidemic in India. Acta Virologica, 1994, 38(1): 25-26.
  • Ismail T.M., Sami A.M., Youssef H.M., Abou Zaid A.A. An outbreak of equine influenza type 1 in Egypt in 1989. Veterinary Medical Journal -Giza, 1990, 38(2): 195-206.
  • Waddell G.H., Teigland M.B., Sigel M.M. A new influenza virus associated with equine respiratory disease. J. Am. Vet. Med. Assoc., 1963, 143: 587-590.
  • Daly J.M., Lai A.C., Binns M.M., Chambers T.M., Barrandeguy M., Mumford J.A. Antigenic and genetic evolution of equine H3N8 influenza A viruses. Journal of General Virology, 1996, 77(4): 661-671 ( )
  • DOI: 10.1099/0022-1317-77-4-66
  • Lai A.C., Chambers T.M., Holland R.E. Jr., Morley P.S., Haines D.M., Townsend H.G., Barrandeguy M. Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Arch. Virol., 2001, 146(6): 1063-1074 ( )
  • DOI: 10.1007/s007050170106
  • Юров К.П., Алексеенкова С.В., Юров Г.К., Иванов В.В. Генотипирование и филогенетический анализ вируса гриппа лошадей H3N8. Ветеринария, 2011, 6: 22-25.
  • Alves Beuttemmuller E., Woodward A., Rash A., Dos Santos Ferraz L.E., Fernandes Alfieri A., Alfieri A.A., Elton D. Characterisation of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012. Virology Journal, 2016, 13: 45 ( )
  • DOI: 10.1186/s12985-016-0503-9
  • Woodward A.L., Rash A.S., Blinman D., Bowman S., Chambers T.M., Daly J.M., Damiani A., Joseph S., Lewis N., McCauley J.W., Medcalf L., Mumford J., Newton J.R., Tiwari A., Bryant N.A., Elton D.M. Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012. Veterinary Microbiology, 2014, 169(3-4): 113-127 ( )
  • DOI: 10.1016/j.vetmic.2013.11.039
  • Rash A., Morton R., Woodward A., Maes O., McCauley J., Bryant N., Elton D. Evolution and divergence of H3N8 equine iinfluenza viruses circulating in the United Kingdom from 2013 to 2015. Pathogens, 2017, 6(1): 6 ( )
  • DOI: 10.3390/pathogens6010006
  • Fougerolle S., Legrand L., Lecouturier F., Sailleau C., Paillot R., Hans A., Pronost S. Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors. Virology, 2017, 505: 210-217 ( )
  • DOI: 10.1016/j.virol.2017.02.003
  • Yondon M., Heil G.L., Burks, J.P., Zayat B., Waltzek T.B., Jamiyan B.O., McKenzie P.P., Krueger W.S., Friary J.A., Gray G.C. Isolation and characterization of H3N8 equine influenza A virus associated with the 2011 epizootic in Mongolia. Influenza and Other Respiratory Viruses, 2013, 7(5): 659-665 ( )
  • DOI: 10.1111/irv.12069
  • Qi T., Guo W., Huang W.Q., Li H.M., Zhao L.P., Dai L.L., He N., Hao X.F., Xiang W.H. Genetic evolution of equine influenza viruses isolated in China. Archives of Virology, 2010, 155(9): 1425-1432 ( )
  • DOI: 10.1007/s00705-010-0724-y
  • Cowled B., Ward M.P., Hamilton S., Garner G. The equine influenza epidemic in Australia: spatial and temporal descriptive analyses of a large propagating epidemic. Preventive Veterinary Medicine, 2009, 92(1-2): 60-70 ( )
  • DOI: 10.1016/j.prevetmed.2009.08.006
  • Yamanaka T., Niwa H., Tsujimura K., Kondo T., Matsumura T. Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. Journal of Veterinary Medical Science, 2008, 70(6): 623-625 ( )
  • DOI: 10.1292/jvms.70.623
  • Ito M., Nagai M., Hayakawa Y., Komae H., Murakami N., Yotsuya S., Asakura S., Sakoda Y., Kida H. Genetic analyses of an H3N8 influenza virus isolate, causative strain of the outbreak of equine influenza at the Kanazawa racecourse in Japan in 2007. Journal of Veterinary Medical Science, 2008, 70(9): 899-906 ( )
  • DOI: 10.1292/jvms.70.899
  • Virmani N., Bera B.C., Singh B.K., Shanmugasundaram K., Gulati B.R., Barua S., Vaid R.K., Gupta A.K., Singh R.K. Equine influenza outbreak in India (2008-09): Virus isolation, sero-epidemiology and phylogenetic analysis of HA gene. Veterinary Microbiology, 2010, 143(2-4): 224-237 ( )
  • DOI: 10.1016/j.vetmic.2009.12.007
  • Perglione C.O., Gildea S., Rimondi A., Miño S., Vissani A., Carossino M., Cullinane A., Barrandeguy M. Epidemiological and virological findings during multiple outbreaks of equine influenza in South America in 2012. Influenza and Other Respiratory Viruses, 2016, 10(1): 37-46 ( )
  • DOI: 10.1111/irv.12349
  • Kydyrmanov A.I., Kumekbayeva Zh.Zh., Karamendin K.O., Daulbayeva K.D., Shakhvorostova L.I., Zhumatov K.Kh. Isolation of an influenza virus A (H3N8) from horses in Kazakhstan in 2007. Veterinarya, 2009, 5: 52-54.
  • Yondon M., Heil G.L., Burks, J.P., Zayat B., Waltzek T.B., Jamiyan B.O., McKenzie P.P., Krueger W.S., Friary J.A., Gray G.C. Isolation and characterization of H3N8 equine influenza A virus associated with the 2011 epizootic in Mongolia. Influenza and Other Respiratory Viruses, 2013, 7(5): 659-665 ( )
  • DOI: 10.1111/irv.12069
  • Yang H., Xiao Y., Meng F., Sun F., Chen M., Cheng Z., Chen Y., Liu S., Chen H. Emergence of H3N8 equine influenza virus in donkeys in China in 2017. Veterinary Microbiology, 2018, 214: 1-6 ( )
  • DOI: 10.1016/j.vetmic.2017.11.033
  • Сарыглар Л.К., Коломыцев А.А., Смирнов В.Н., Куулар Р.К., Достай С.М., Муруева Г.Б. Эпизоотический процесс гриппа лошадей в Бурятии и Тыве в 2008 г., обусловленный вирусом гриппа подтипов Н7 и Н3. Ветеринарная патология, 2009, 4: 41-46.
  • OIE. Chapter 2.5.7 Equine influenza. In manual of diagnostic tests and vaccines for terrestrial animals. OIE, Paris, 2016: 1-16. Режим доступа: http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/3.05.07_EQ_INF.pdf. Дата обращения 15.04.2019.
  • OIE Expert surveillance panel on equine influenza vaccine composition, OIE Headquarters, 28 March 2018. The World Organisation for Animal Health (OIE), 2017: 86-87. Режим доступа: http://www.oie.int/en/our-scientific-expertise/specific-information-and-recommendations/equine-influenza/. Без даты.
  • Wong S.S., Webby R.J. Traditional and new influenza vaccines. Clinical Microbiology Reviews, 2013, 26: 476-492 ( )
  • DOI: 10.1128/CMR.00097-12
  • Baker D.J. Rationale for the use of influenza vaccines in horses and the importance of antigenic drift. Equine Veterinary Journal, 1986, 18(2): 93-96 ( )
  • DOI: 10.1111/j.2042-3306.1986.tb03554.x
  • Palliot R., Pitel C.M., D'Ablon X., Pronost S. Equine Vaccines: how, when and why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims. Vaccines, 2017, 5(4): 46 ( )
  • DOI: 10.3390/vaccines5040046
  • Юров К.П., Жидков С.А. Испытание инактивированной вакцины против гриппа лошадей. Бюллетень Всесоюзного ордена Ленина научно-исследовательского института экспериментальной ветеринарии им. Я.Р. Коваленко, 1972, 14: 47-50.
  • Paillot R., Hannant D., Kydd J.H., Daly J.M. Vaccination against equine influenza: Quid novi? Vaccine, 2006, 24(19): 4047-4061 ( )
  • DOI: 10.1016/j.vaccine.2006.02.030
  • Paillot R., Prowse L., Montesso F., Huang C.M., Barnes H., Escala J. Whole inactivated equine influenza vaccine: efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity. Vet. Microbiol., 2013, 162: 396-407 ( )
  • DOI: 10.1016/j.vetmic.2012.10.019
  • Nelson K.M., Schram B.R., McGrergor M.W., Sheoran A.S., Olsen C.W., Lunn D.P. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine, 1998, 16(13): 1306-1313 ( )
  • DOI: 10.1016/S0264-410X(98)00009-7
  • Исаенко Е.Ю., Бабич Е.М., Елисеева И.В., Ждамарова Л.А., Белозерский В.И., Колпак С.А. Адъюванты в современной вакцинологии. Annals of Mechnikov Institute, 2013, 4: 5-21.
  • Elton D., Bryant N. HBLB's advances in equine veterinary science and practice. Facing the threat of equine influenza. Equine Veterinary Journal, 2011, 43(3): 250-258.
  • Holmes M.A., Townsend H.G., Kohler A.K., Hussey S., Breathnach C., Barnett C., Holland R., Lunn D.P. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Veterinary Immunology and Immunopathology, 2006, 111(1-2): 67-80 ( )
  • DOI: 10.1016/j.vetimm.2006.01.010
  • Youngner J.S., Whitaker-Dowling P., Chambers T.M., Rushlow K.E., Sebring R. Derivation and characterization of a live attenuated equine influenza vaccine virus. American Journal of Veterinary Research, 2001, 62(8): 1290-1294.
  • Lunn D.P., Hussey S., Sebing R., Rushlow K.E., Radecki S.V., Whitaker-Dowling P., Youngner J.S., Chambers T.M., Holland Jr. R.E., Horohov D.W. Safety, efficacy and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. Journal of the American Veterinary Medical Association, 2001, 218(6): 900-906 ( )
  • DOI: 10.2460/javma.2001.218.900
  • Chambers T.M., Holland R.E., Tudor L.R., Townsend H.G.G., Cook A., Bogdan J., Lunn D.P., Hussey S., Whitaker-Dowling P., Youngner J. S., Sebring R.W., Penner S.J., Stiegler G.L. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Equine Veterinary Journal, 2001, 33(7): 630-636 ( )
  • DOI: 10.2746/042516401776249291
  • Chervyakova O., Strochkov V., Tailakova E., Sultankulova K., Sandybayev N., Sansyzbay A., Gorev N., Sergeeva M., Potapchuk M., Repko I., Tsybalova L., Kiselev O. Recombinant strain A/HK/Otar/6:2/2010 (H3N8) for development of a live intranasal equine influenza vaccine. Journal of Equine Veterinary Science, 2014, 34(6): 749-758 ( )
  • DOI: 10.1016/j.jevs.2014.01.003
  • Tabynov K. A new safe and effective cold-adapted modified live equine influenza virus vaccine that enables the differentiation of infected from vaccinated animals. Microbiology Independent Research Journal, 2016, 3(1): 68-73 ( )
  • DOI: 10.18527/2500-2236-2016-3-1-68-73
  • Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proceedings of the National Academy of Sciences, 2000, 97(11): 6108-6113 ( )
  • DOI: 10.1073/pnas.100133697
  • Jung E.-J., Lee K.-H., Seong B.L. Reverse genetic platform for inactivated and live-attenuated influenza vaccine. Experimental & Molecular Medicine, 2010, 42(2): 116-121 ( )
  • DOI: 10.3858/emm.2010.42.2.013
  • Richt J.A., Lekcharoensuk P., Lager K.M., Vincent A.L., Loiacono C.M., Janke B.H., Wu W.H., Yoon K.J., Webby R.J., Solorzano A., Garcia-Sastre A. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. Journal of Virology, 2006, 80(22): 11009-11018 ( )
  • DOI: 10.1128/JVI.00787-06
  • Забережный А.Д., Гребенникова Т.В., Воркунова Г.К., Южаков А.Г., Костина Л.В., Норкина С.Н., Алипер Т.И., Непоклонов Е.А., Львов Д.К. Получение нового штамма-реассортанта вируса гриппа A/H5N1 методом обратной генетики и анализ его биологических свойств. Вопросы вирусологии, 2014, 59(6): 23-27.
  • Uchida Y., Takemae N., Saito T. Application of reverse genetics for producing attenuated vaccine strains against highly pathogenic avian influenza viruses. Journal of Veterinary Medical Science, 2014, 76(8): 1111-1117 ( )
  • DOI: 10.1292/jvms.13-062
  • Quinlivan M., Zamarin D., Garcia-Sastre A., Cullinane A., Chambers T., Palese P. Attenuation of equine influenza viruses through truncations of the NS1 protein. Journal of Virology, 2005, 79(13): 8431-8439 ( )
  • DOI: 10.1128/JVI.79.13.8431-8439.2005
  • Chambers T.M., Quinlivan M., Sturgill T., Cullinane A., Horohov D.W., Zamarin D., Arkins S., Garcia-Sastre A., Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: Pilot studies of safety and efficacy in horses. Equine Veterinary Journal, 2009, 41(1): 87-92 ( )
  • DOI: 10.2746/042516408X371937
  • Rodrigueza L., Reedyb S., Nogalesa A., Murciac P.R., Chambersb T.M., Martinez-Sobridoa L. Development of a novel equine influenza virus live-attenuated vaccine. Virology, 2018, 516: 76-85 ( )
  • DOI: 10.1016/j.virol.2018.01.005
  • Baz M., Paskel M., Matsuoka Y., Zengel J., Cheng X., Treanor J.J., Jin H., Subbarao K. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. Journal of Virology, 2015, 89: 1652-1659 ( )
  • DOI: 10.1128/JVI.02449-14
  • Draper S.J., Heeney J.L. Viruses as vaccine vectors for infectious diseases and cancer. Nature Reviews Microbiology, 2010, 8(1): 62-73 ( )
  • DOI: 10.1038/nrmicro2240
  • Breathnach C.C., Clark H.J., Clark R.C., Olsen C.W., Townsend H.G., Lunn D.P. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Vaccine, 2006, 24: 1180-1190 ( )
  • DOI: 10.1016/j.vaccine.2005.08.091
  • Paillot R., Rash N., Garrett D., Prowse-Davis L., Montesso F., Cullinane A., Lemaitre L., Thibault J.-C., Wittreck S., Dancer A. How to meet the last OIE expert surveillance panel recommendations on equine influenza (EI) vaccine composition: a review of the process required for the recombinant Canarypox-based EI vaccine. Pathogens, 2016, 5(4): 64 ( )
  • DOI: 10.3390/pathogens5040064
  • Paillot R., El-Hage C.M. The use of a recombinant canarypox-based equine influenza vaccine during the 2007 Australian outbreak: a systematic review and summary. Pathogens, 2016, 5(2): 42 ( )
  • DOI: 10.3390/pathogens5020042
  • Poulet H., Minke J., Pardo M. C., Juillard V., Nordgren B., Audonnet J.-C. Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform. Vaccine, 2007, 25(30): 5606-5612 ( )
  • DOI: 10.1016/j.vaccine.2006.11.066
  • Minke J.M., Toulemonde C.E., Coupier H., Guigal P.M., Dinic S., Sindle T., Jessett D., Black L., Bublot M., Pardo M.C., Audonnet J.C. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. American Journal of Veterinary Research, 2007, 68(2): 213-219 ( )
  • DOI: 10.2460/ajvr.68.2.213
  • Soboll G., Hussey S.B., Minke J.M., Landolt G.A., Hunter J.S., Jagannatha S., Lunn D.P. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC®) vaccination. Veterinary Immunology and Immunopathology, 2010, 135(1-2): 100-107 ( )
  • DOI: 10.1016/j.vetimm.2009.11.007
  • Van de Walle G.R., May M.A., Peters S.T., Metzger S.M., Rosas C.T., Osterrieder N. A vectored equine herpesvirus type 1 (EHV-1) Vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus. Vaccine, 2010, 28(4): 1048-1055 ( )
  • DOI: 10.1016/j.vaccine.2009.10.123
  • Nogales A., Martínez-Sobrido L. Reverse genetics approaches for the development of influenza vaccines. Int. J. Mol. Sci., 2017, 18(1): 20 ( )
  • DOI: 10.3390/ijms18010020
Еще
Статья обзорная